Orasi service aims to cuts costs in Alzheimer’s trials
Orasi Medical claims CROs and pharmas can cut the cost and length of Alzheimer’s trials, and improve accuracy, by using its brain function measuring service, which is now being promoted in Japan.
Makro’s GCP helpdesk a hit among CROs
Hyderabad, India-based Makro Care says its GCP “helpdesk” website has already proved to be an invaluable information source for contract research organisations (CRO), investigators and pharma trial sponsors.
SynRG makes big time saving by automating; opens US office
Russia-based CRO SynRG has cut the time to prepare a detailed proposal from two weeks to two hours, giving the company a competitive advantage over its rivals, and established a presence in the US to target small to mid-sized companies.
Share your thoughts on EDC and eClinical tech
IT group TechTeam Global and the eClinical Forum are asking Outsourcing-Pharma’s readers to take part in an online survey examining the use of eClinical technologies and electronic data capture (EDC).
Biomarkers big business, Advion expands LC-MS capacity
US contract research organisation (CRO) Advion BioServices has expanded its biomarker business in an effort to meet growing industry demand for pharmacological analysis.
Aushon expands facility to meet biomarker service demand
Aushon BioSystems has added laboratory and manufacturing capacity to its corporate headquarters to meet rising demand from clinical trials for some of its protein biomarker services.
Covance sets up trial offices Brazil and Mexico
Covance says its new clinical development offices in Brazil and Mexico will increase access to treatment-naïve patients and, ultimately, save pharmaceutical sponsors money.
Pacific Biometrics boosts biomarker biz with $4m loan
US CRO and central laboratory services provider Pacific Biometrics (PBI) has entered into a $4m (€2.7m) loan agreement that it says will help further the development of its contract biomarkers business.
AZ cuts Phase I initiation time
AstraZeneca (AZ) has dramatically cut the time taken to initiate a Phase I oncology trial by working with its strategic partner to improve administrative processes and eliminate delays, according to research.
CROs can make “enormous leap” with adaptive operations
An “enormous leap in productivity” can be achieved by applying the principles of adaptive trials to broader operations, such as recruitment, according to a CEO that thinks CROs have to adopt the method.
Synexus brings high recruitment rate methods to new sites in Poland
Synexus is meeting the rising demand for its services, which it says can dramatically increase recruitment rates, by acquiring clinical trial sites in Poland and is hoping to expand in India soon.
goBalto adds sites in “high growth” Latin American market
Drug development partnering site goBalto’s addition of Latin American clinical sites to its database in a deal with Chilean CRO Clinical Trials Support (CTS) is timely given the pharma and biotech industry’s focus on emerging markets.
Number of trials registered with Russia’s RZN falls 17% in Q2
The number of registered clinical trials in Russia slipped in Q2, with the country attracting fewer international sponsors and regulatory inspections than in pervious years.
Proteomics lab receives accreditation
Proteomics International has become the first service laboratory of its kind to receive ISO/IEC 17025 accreditation from NATA, an Australian agency.
CRL teams up with Quotient for new European lab
US analysis group CRL will set up a new laboratory at Quotient Bioresearch’s facility in Cambridge in the UK, in a collaboration designed to expand the US company’s business on the global stage and extend Quotient's offering.
Sigma-Aldrich develops knockout rats
Sigma-Aldrich is using a novel methodology to create rats with targeted gene deletion in as little as four months, which it believes could eliminate years of research and improve drug development.
Xceleron providing services to GSK & collaborators
Xceleron will provide services to GSK and its collaborators, such as academics and biotechs, under a novel deal that emphasises the big pharma’s attempts to change its drug development model.
Pfizer and Private Access team up for trial recruitment website
US drug giant Pfizer has joined the growing list of organisations seeking to boost trial recruitment via the web, teaming up with IT firm Private Access to create a website designed to “increase clinical trial awareness and participation.”
CenterWatch and TrialX hope to boost recruitment via web 2.0
A new partnership between CenterWatch and TrialX may help boost flagging recruitment rates by “helping patients more easily and rapidly connect with relevant clinical trials.”
Vimta licenses tech to cut diagnostic costs
India-based CRO Vimta Labs is aiming to lower the cost of diagnostic services by developing new panels using MassTag PCR technology licensed from Columbia University, New York.
Medidata turns loss to profit in Q2
Medidata has followed its successful IPO by posting an operating profit in Q2, having made a loss last year, and giving a positive outlook for the rest of the year.
OmniComm buys more EDC assets
OmniComm has acquired Logos Technologies’ electronic data capture (EDC) assets, the second deal of this type it has made in the past 6 weeks, further strengthening its presence in the market.
Pfizer teams helps Fudan University found clinical data management MSc
US pharmaceutical giant Pfizer has teamed up with China’s Fudan University to set up a Master’s degree programme in clinical data management and statistical programming.
Ecron Acunova teams up with Essential CRO and Biotrial
Ecron Acunova’s global partnering team had a busy end to July with the Indian CRO entering into collaboration deals on both sides of the Atlantic to further expand its global reach.
Covance doubles metabolite testing capacity
US CRO Covance has expanded its preclinical development offering, doubling metabolite identification capacity at its facility in Madison, Wisconsin.
Isogen's new science centre a "unique" clinical service facility
US firm Isogen says the combination of aseptic filling, engineering and containment know-how on offer at its new Science Center is unique among facilities serving the clinical market.
Phase Forward's income drops in Q2
Phase Forward’s GAAP net income fell by 41 per cent in Q2 despite an increase in revenues, as rising operating costs hit the company.
Developing world trials meet standards and speed drugs to market, says ACRO
Clinical trials in the developing world meet the same standards as those in Europe and the US and are vital for accelerating drug development says the Association of Clinical Research Organisations (ACRO).
PRA opens South Korean office
US CRO PRA International has opened a new office in South Korea, further extending its presence in Asia.
Phase Forward buys Covance’s web business for $10m
US data management and collection specialist Phase Forward will pay $10m (€7m) for Covance’s interactive voice and web response business (IVRS/IWRS).
“Velos on-demand” launched to help CROs cut spending
US software company Velos hopes its new “software as a service” (SaaS) internet offering will attract CROs and Pharma firms seeking low-cost trial management solutions.
KDH hopes PatientLocate will change recruitment paradigm
US software development firm KDH Systems has unveiled a new platform that it claims will change “the paradigm of clinical trial patient recruitment.”
QPS partners Taiwan’s DCB and extends offering
US contract research organisation (CRO) QPS has been called in by the Taiwanese Development Center for Biotechnology (DCB) to provide support services for biotech firms operating in the region.
WuXi only CRO to make China’s list of top ten outsourcers
Shanghai based CRO WuXi PharmaTech has been named as one of China’s top ten outsourcing enterprises in 2008 by the country’s Ministry of Commerce.
Medidata inks EDC deal with Roche
Medidata has followed up its successful IPO by inking a deal with Roche, which is reported to be pulling out of PhRMA and the ABPI, to provide the Swiss pharma with an enterprise-wide electronic EDC system.
Phase Forward signs new deal with GSK
Data management specialist Phase Forward has landed a “multi-million dollar” clinical trial services contract with GSK.
Chiltern sets up in Hungary
UK group Chiltern International has opened an office in Budapest Hungary, joining the growing number of CRO players to set up in the CEE.
Synteract sets up in Czech Republic joining CRO CEE rush
Synteract will open an office in Prague in the Czech Republic, joining the growing number of CROs to offer sponsors access to treatment naive populations in Central and Eastern Europe (CEE).
More trial info would boost physician referrals, says CenterWatch
Physicians say a lack of information about candidate drugs often prevents them referring patients for clinical trials, according to a new survey by sector analysts CenterWatch.
Icon partners to create translational research site
Icon has entered into a collaboration with the Central Manchester University Hospitals Foundation (CMFT) to establish a purpose built translational medicine facility in the UK.
Quintiles sets up in Ghana to boost recruitment pool
UK CRO Quintiles Transnational has set up an office in Accra, Ghana in a move it claims allows it to recruit trial participants from sub-Saharan Africa’s estimated 760m residents.
DZS rolls out ClinPlus CTMS for complex trials
US group DZS Software Solutions says its new web ClinPlus CTMS technology will help sponsors and CROs ensure that trial procedures are being followed and eliminate redundant study management systems.
Cogenics rolls out new 1,936 marker DMET screening service
US genomic services specialist Cogenics has launched a new DMET analysis service that it believes will improve patient genotyping during clinical trials, helping drug industry sponsors target the development of new products and reduce costs.
Microsoft adds genomics capacity to Amalga
Microsoft is ramping up its efforts in drug R&D for personalised medicine through the acquisition of genomic analysis technology developed by Seattle, US firm Rosetta Biosoftware.
Merge Healthcare to acquire eTrials after Bio-Imaging bid collapses
IT solutions firm Merge Healthcare has won the race to buy eClinical specialist etrials, beating previous suitor Bio-Imaging Technologies whose takeover bid collapsed on Monday.
MDS sells late stage trial unit to INC Research
Canadian CRO MDS Pharma Services (MDS) is to sell its Phase II-IV trial business to US counterpart INC Research for $50m (€35m) and focus on providing discovery and early clinical development services.
Kendle further expands Asia-Pacific presence
US CRO Kendle has set up three units in Malaysia, Thailand and the Philippines, further demonstrating the growing importance of the Asia Pacific for the contract research sector.
BKK sets up in Japan to combat recruitment lag
US Patient recruitment specialist BBK Worldwide has set up a unit in Osaka, Japan to improve enrolment rates for studies in the country and help local pharma and biotech firms cut costs.
Ockham and etrials team up on EDC
US CRO Ockham Development group will start providing customers with data capture and analysis solutions developed by etrials under a new, five year licensing agreement.
Fate seeks partners to be iPS Catalyst
There has been “tremendous interest” in Fate Therapeutics’ Catalyst programme, which gives access to induced iPS cell technology as part of collaborative relationship between numerous companies.